Crispr Therapeutics AG(CH:1CG)
CHF 39.800.00 (0.00%)
CH:1CG
Crispr Therapeutics AG Revenue
CHF 39.80
At close:0.00 (0.00%)
Crispr Therapeutics AG (1CG) Revenue
2 Followers
Crispr Therapeutics AG Revenue
Crispr Therapeutics AG had a revenue of 12.67M in the quarter ending Sep 30, 2026, with 24.44%. This bring the company's revenue in the last twelve months to 25.17M, Increased 87.96%. In the fiscal year ending Dec 31, 2025, Crispr Therapeutics AG had annual revenue of 3.51M with -89.97% growth.
- Revenue (ttm)
- 25.17M
- Revenue Growth
- -39.86%
- P/S Ratio
- 1038.44
- Revenue/Employee
- CHF 8,931
- Employees
- 393
- Market Cap
- CHF 3.64B
Revenue Chart
Crispr Therapeutics AG Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.51M | -31.49M | -89.97% |
| Dec 31, 2024 | 35.00M | -335.00M | -90.54% |
| Dec 31, 2023 | 370.00M | 369.56M | 84762.39% |
| Dec 31, 2022 | 436.00K | -912.64M | -99.95% |
| Dec 31, 2021 | 913.08M | 912.36M | 126893.18% |
| Dec 31, 2020 | 719.00K | -288.87M | -99.75% |
| Dec 31, 2019 | 289.59M | 286.47M | 9169.85% |
| Dec 31, 2018 | 3.12M | -37.87M | -92.38% |
| Dec 31, 2017 | 41.00M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.